Photo of Maritza Davila
D New York Assembly · District 53 On the 2026 ballot

Asm. Maritza Davila

Compare
Total votes
9,713
all sessions
Attendance
86%
1,330 missed
Lower than 84% of chamber peers
With party
99%
of cast votes
Higher than 93% of chamber peers
Bipartisan score
0%
crosses aisle rarely
Lower than 94% of chamber peers
Sponsored
1,510
bills & resolutions
Higher than 87% of chamber peers
Committees
10
assignments
1,510 bills and resolutions

Sponsored bills

Total
1,510
Primary
83
Co-sponsor
1,427
This page
1,510
matching current filters
Co-sponsor A 7119
In committee · New York Assembly · Co-sponsor
Relates to attachments to utility poles for broadband service

Relates to attachments to utility poles for broadband service; provides that for a broadband internet provider that does not provide regulated telephone service, a pole owner shall not require such broadband internet provider to obtain a certificate of public convenience and necessity as a condition to making attachments to utility poles solely owned or jointly-owned by the pole owner.

In committee Jan 3, 2024 1 co-sponsor
Co-sponsor A 7072
In committee · New York Assembly · Co-sponsor
Relates to arrest, prosecution, sentencing and penalties for offenses involving vehicular assault, manslaughter and homicide and operating a vehicle under the influence of drugs or alcohol

Amends provisions involving the arrest, prosecution, sentencing and penalties for offenses involving vehicular assault, manslaughter and homicide; removes certain barriers to prosecution for operating a vehicle under the influence of drugs or alcohol.

In committee Jan 3, 2024 1 co-sponsor
Co-sponsor A 7465
In committee · New York Assembly · Co-sponsor
Preserves access to affordable drugs

Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

In committee Jan 3, 2024 1 co-sponsor
Showing 1,141 to 1,150 of 1,510 bills